Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentaglobin for critically ill ICU patients with COVID-19
IRCT20150107020592N27Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2020
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Pentaglobin in coronavirus disease 2019 (COVID-19), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Improve oxygenation and Improve CT scans. Started Mar 2020; status: completed.
02
Drugs
Pentaglobin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20150107020592N27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150107020592N27.